A Pharmacokinetic Study of Different Quercetin Formulations in Healthy Participants: A Diet-Controlled, Crossover, Single- and Multiple-Dose Pilot Study.

Evid Based Complement Alternat Med · 2023 · PMC10435304 · PMID 37600550

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

These data on quercetin LM conjugates may be significant for enhancing the biological effects such as the antioxidant properties of quercetin and its conjugated derivatives in the body.

also in 7,717 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.